Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Innovative Medical |
---|---|
Information provided by: | Innovative Medical |
ClinicalTrials.gov Identifier: | NCT00347802 |
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.
Condition | Intervention | Phase |
---|---|---|
Glaucoma |
Drug: Bimatoprost 0.03%, Travoprost 0.004% |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind, Active Control, Parallel Assignment |
Official Title: | Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004% |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
· Male or female > 18 years of age
Exclusion Criteria:
· Known contraindication to bimatoprost or travoprost, or any component of any study medication
Study ID Numbers: | 5176 |
Study First Received: | June 30, 2006 |
Last Updated: | May 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00347802 History of Changes |
Health Authority: | United States: Institutional Review Board |
Bimatoprost Glaucoma Eye Diseases Cardiovascular Agents |
Antihypertensive Agents Travoprost Hypertension Ocular Hypertension |
Bimatoprost Glaucoma Therapeutic Uses Eye Diseases Cardiovascular Agents |
Antihypertensive Agents Pharmacologic Actions Travoprost Ocular Hypertension |